Navigation Links
Top Bristol-Myers Squibb Executive Joins Patton Boggs
Date:2/18/2010

WASHINGTON, Feb. 18 /PRNewswire-USNewswire/ -- Patton Boggs LLP has hired Dick Thompson, a top executive at Bristol-Myers Squibb with nearly four decades of public policy experience, to strengthen its hand in the healthcare and pharmaceutical sectors.

Mr. Thompson joins the firm as senior counsel in its Washington office where he will utilize his extensive experience with complex health and pharmaceutical policy issues to help clients navigate a challenging political environment.

"It is a major coup to have such a highly experienced and well-respected leader like Dick Thompson join the firm," said Stuart M. Pape, managing partner of the firm. "Our clients will benefit from his deep industry connections, significant government affairs prowess and experience as an executive at a major international powerhouse like Bristol-Myers Squibb."

Mr. Thompson, known as the "Dean" of the pharmaceutical industry corporate representatives, is a respected leader in the public policy and pharmaceutical industries. He spent the past decade as Bristol-Myers Squibb's senior vice president for policy and government affairs where he established and led a 45-member global staff.

As a member of the Bristol-Myers Squibb's operating committee, Mr. Thompson represented the company to key industry associations and managed the development of major public policy positions. At the time of his retirement in December 2009, Mr. Thompson had served as head of the Washington office for more than 26 years, longer than any current or former industry executive.

During his tenure, he worked to move the company to the top tier of advocacy in the pharmaceutical industry, pioneered a new international government affairs program and led the integration of the government affairs staff in the merger of the Bristol-Myers and Squibb companies.

"Patton Boggs has long been regarded as the premier public policy firm in the country, and I am excited to join such an exalted team," Mr. Thompson said. "I look forward to utilizing my experience at Bristol-Myers Squibb to help clients from the pharmaceutical and other industries achieve their strategic business and policy objectives."

Mr. Thompson spent nearly eight years working on Capitol Hill, including three years as Republican staff director and chief counsel to what is now known as the House Committee on Government Oversight and Reform.

Mr. Thompson moved to Washington in 1970 after serving two years in the U.S. Army, including a tour in Vietnam where he earned the rank of captain.

Mr. Thompson is active in many charitable and civic organizations. He is a vice chairman and trustee of Syracuse University, where he received his master's degree from the Maxwell School of Citizenship and Public Affairs. In addition, he has served as the president and a board member of the Carlton Club, chair of Ford Theatre's board of trustees and as chair of the governance committee and a member of the board of directors of Meridian International Center. He serves as a member of the Federal City Council.

Patton Boggs LLP

Based in Washington, D.C., Patton Boggs is a leader in public policy, litigation, and business law, and is well known for its deep bipartisan roots in the U.S. political arena. The firm's core practice areas are Public Policy and Regulatory, Litigation, Business, and Intellectual Property. With offices in New York, New Jersey, Dallas, Denver, Anchorage, Northern Virginia and internationally in Doha, Qatar and Abu Dhabi, United Arab Emirates, more than 600 lawyers and professionals provide comprehensive, practical and cost-effective legal counsel to clients around the globe. For more information, visit us at www.pattonboggs.com. To receive press releases from Patton Boggs, please contact Rebecca Carr at rcarr@pattonboggs.com.

SOURCE Patton Boggs LLP

RELATED LINKS
http://www.pattonboggs.com

'/>"/>

SOURCE Patton Boggs LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe
2. Bristol-Myers Squibb, New Jersey Childrens Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
3. Babson Executive Education Offers Bio-Pharma: Mastering the Business of Science
4. Encorium Re-Appoints Dr. Kai Lindevall as Chief Executive Officer and Appoints Current Director, Shahab Fatheazam, Chairman of the Board
5. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
6. Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive
7. Shu-Tung Li, Founder and CEO of Collagen Matrix, Inc. Honored as 2009 New Jersey Executive of the Year and Company Named Sixteenth Fastest Growing Company
8. Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
9. Cardinal Health Executives to Speak at Two Investor Events in January
10. New Executive Leadership and CEO Announced for BiPar Sciences
11. Ascension Orthopedics Hires Key Senior Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... YORK , December 2, 2016 ... Braces & Support) is Expected to Gain a Significant Market ... to Orthopedic Ailments  ... , According to ... Study on Medical Implants Sterile Packaging: Clamshell Product Type Segment ...
(Date:12/2/2016)... Dec. 2, 2016   CytoSorbents Corporation (NASDAQ: ... its European Union approved CytoSorb ® cytokine adsorber ... patients worldwide, announced that Dr. Phillip Chan , ... Annual LD Micro Main Event investor conference held ... the Luxe Sunset Boulevard Hotel in Los ...
(Date:12/2/2016)... YORK , December 2, 2016 ... 5,251.11, down 1.36%; the Dow Jones Industrial Average edged 0.36% ... at 2,191.08, down 0.35%. Losses were broad based as six ... Stock-Callers.com has initiated research reports on the following Services equities: ... (NASDAQ: QGEN ), INC Research Holdings Inc. (NASDAQ: ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame to ... Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking to ... drug plan (Part D) need to make changes during this period order for their ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than half of American teens ... of parents report speaking with their child about sex related topics, less than 60 ... Mediaplanet is proud to announce the launch of its second edition of the “Sexual ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre ... unique properties including its unmatched natural purity of just 6 ppm TDS (Total Dissolved ... , Nothing Water has been available in several ShopRite and FoodTown stores in NJ ...
(Date:12/2/2016)... ... December 02, 2016 , ... On November 24th, 2016, ... from eight different sites throughout Miami-Dade and Broward counties. This is the largest ... hard on Thanksgiving morning by putting together individual meals via assembly lines and ...
(Date:11/30/2016)... ... 30, 2016 , ... Northridge dentists, Dr. Assili ... for all patients. Understanding that budget can play a part in oral health ... perks, including discounts on many valuable dental treatments. Options for individuals, couples, and ...
Breaking Medicine News(10 mins):